Lista de obras -

A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortality

artículo científico publicado en 2018

Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT

scientific article published on 09 April 2019

African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology

artículo científico publicado en 2002

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

artículo científico publicado en 2006

Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals

Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).

artículo científico publicado en 2011

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

artículo científico publicado en 2004

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial

artículo científico publicado en 2007

Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial

artículo científico

Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial

artículo científico publicado en 2012

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial

artículo científico publicado en 2007

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial

artículo científico publicado en 2008

Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial

artículo científico publicado en 2008

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.

artículo científico publicado en 2014

Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.

artículo científico publicado en 2017

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial

artículo científico publicado en 2006

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

artículo científico publicado en 2007

New recommendations for treating hypertension in black patients: evidence and/or consensus?

artículo científico publicado en 2010

Organizational climate and family life: how these factors affect the status of women faculty at one medical school

artículo científico publicado en 2009

Outcomes by gender in the African-American Heart Failure Trial.

artículo científico publicado en 2006

Relating mentor type and mentoring behaviors to academic medicine faculty satisfaction and productivity at one medical school

artículo científico publicado en 2014

Screening for early detection of cardiovascular disease in asymptomatic individuals ⬇️

artículo científico publicado el 1 de octubre de 2003

The African-American Heart Failure Trial: background, rationale and significance.

artículo científico publicado en 2002

The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factors

artículo científico publicado en 2011

Lista de obras de

A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortality

Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT

African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals

Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial

Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial

Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial

Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.

Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

New recommendations for treating hypertension in black patients: evidence and/or consensus?

Organizational climate and family life: how these factors affect the status of women faculty at one medical school

Outcomes by gender in the African-American Heart Failure Trial.

Relating mentor type and mentoring behaviors to academic medicine faculty satisfaction and productivity at one medical school

Screening for early detection of cardiovascular disease in asymptomatic individuals ⬇️

The African-American Heart Failure Trial: background, rationale and significance.

The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factors